Zhangzhou Affiliated Hospital of Fujian Medical University
Zhangzhou Affiliated Hospital of Fujian Medical University
Zhangzhou, Fujian, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC | Disease Attributes, Disease Progression, Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Stomatognathic Diseases, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-07-01 | NCT06811844 | |
| Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2024-10-15 | NCT06602011 | |
| Neoadjuvant Triple Therapy for Resectable HCC | Resectable Hepatocellular Carcinoma | Recruiting | Not stated | 2024-10-15 | NCT06569498 |